These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6671513)

  • 1. Prognostic significance of bridging necrosis in chronic active hepatitis.
    Okuno T; Okanoue T; Takino T; Mori K
    Gastroenterol Jpn; 1983 Dec; 18(6):577-84. PubMed ID: 6671513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis.
    Cooksley WG; Bradbear RA; Robinson W; Harrison M; Halliday JW; Powell LW; Ng HS; Seah CS; Okuda K; Scheuer PJ
    Hepatology; 1986; 6(3):345-8. PubMed ID: 3710424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term prognosis of chronic B and C viral hepatitis].
    Ohlen J; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of liver histology in chronic active hepatitis C and chronic active hepatitis B.
    Shah HA; Kayani N; Sheikh H; Jafri SW; Hamid S; Khan AH
    Indian J Gastroenterol; 1995 Jul; 14(3):91-4. PubMed ID: 7544766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural course of chronic hepatitis C.
    Takahashi M; Yamada G; Miyamoto R; Doi T; Endo H; Tsuji T
    Am J Gastroenterol; 1993 Feb; 88(2):240-3. PubMed ID: 8424428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic active hepatitis in alcoholic patients.
    Crapper RM; Bhathaland PS; Mackay IR
    Liver; 1983 Oct; 3(5):327-37. PubMed ID: 6645817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of pre- and post-treatmental hepatohistology with heavy dosage of Paeonia rubra on chronic active hepatitis caused liver fibrosis].
    Yang DG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Apr; 14(4):207-9, 195. PubMed ID: 7950194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic marker.
    Schlichting P; Fauerholdt L; Christensen E; Poulsen H; Juhl E; Tygstrup N
    Liver; 1982 Jun; 2(2):104-12. PubMed ID: 7176839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe chronic active liver disease. Prognostic significance of initial morphologic patterns.
    Schalm SW; Korman MG; Summerskill WH; Czaja AJ; Baggenstoss AH
    Am J Dig Dis; 1977 Nov; 22(11):973-80. PubMed ID: 920708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic study of chronic active hepatitis C; comparison with chronic active hepatitis B.
    Hahm KB; Chon CY; Kim WH; Han KH; Chung JB; Lee SI; Moon YM; Kang JK; Park IS; Choi HJ
    Korean J Intern Med; 1992 Jul; 7(2):102-10. PubMed ID: 1306071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen.
    Schlichting P; Hølund B; Poulsen H
    Scand J Gastroenterol; 1983 Jan; 18(1):27-32. PubMed ID: 6675176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis of chronic aggressive hepatitis. A clinical and morphological follow-up study.
    Dietrichson O; Christoffersen P
    Scand J Gastroenterol; 1977; 12(3):289-95. PubMed ID: 866990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamics of chronic active hepatitis with varying degrees of severity].
    Serov VV; Aprosina ZG; Popov MS; Popova IV; Tikhonova GN
    Arkh Patol; 1981; 43(8):12-27. PubMed ID: 6457594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients.
    Rao KV; Kasiske BL; Anderson WR
    Transplantation; 1991 Feb; 51(2):391-6. PubMed ID: 1994533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lichen planus and chronic active hepatitis. A retrospective survey.
    Rebora A; Rongioletti F
    Acta Derm Venereol; 1984; 64(1):52-6. PubMed ID: 6203283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
    Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
    Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers.
    Sampliner RE; Hamilton FA; Iseri OA; Tabor E; Boitnott J
    Am J Med Sci; 1979; 277(1):17-22. PubMed ID: 425995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histological aspects of chronic HCV infection and cirrhosis.
    Giusti G; Pasquale G; Galante D; Russo M; Sardaro C; Gallo C; Gaeta GB
    Hepatogastroenterology; 1993 Aug; 40(4):365-9. PubMed ID: 8406307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute viral hepatitis B with bridging necrosis: a follow-up study.
    Schmid M; Pirovino M; Altorfer J; Bansky G; Bühler H; Gudat F; Bianchi L
    Liver; 1981 Sep; 1(3):222-9. PubMed ID: 7348758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.